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Abstract
The temporomandibular joint (TMJ) forms a complex functional system with teeth, 
bones, connected muscles and ligaments. Any discomfort in any of these structures 
directly affects the joint. The complaints are mostly pain, malocclusion and swelling. 
Temporomandibular joint tumors are very uncommon but show symptoms similar to 
intra-articular disorders that make up most of these disorders. The most common TMJ-
specific benign tumors are classified after a brief literature review. Our classification also 
includes the osteoma of the TMJ, other than World Health Organization’s (WHO) classifi-
cation of soft tissue and bone tumors. This benign tumor was also included in the classifi-
cation because of its higher frequency in the literature. The treatment of these neoplasms 
may be conservative or radical surgery.
Keywords: cartilage tumors, temporomandibular joint tumors, cartilage tumors, 
osteogenic tumors, osteochondroma, chondroma, chondroblastoma, pigmented 
villonodular synovitis, synovial chondromatosis, osteoma, juxta-articular  
myxoma
1. Introduction
Primary neoplasms of the bones are rare, amounting to only 0.2% of the overall human 
tumor. Primary neoplasms originating in the temporomandibular joint (TMJ) are extremely 
rare. Their clinical manifestations are usually related to the temporomandibular dysfunction 
(TMD) and include pre-auricular swelling, pain, trismus, deviation of mandibular movement 
and malocclusion. Such symptoms should not be neglected and advanced imaging meth-
ods should be used with the thought that it may be neoplasia. Also the clinical symptoms 
and radiological appearance of many tumors are similar. Therefore, the differential diagnosis 
must be made carefully [1].
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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Temporomandibular joint consists of bone structures and soft tissues such as temporal bone, 
mandibular condyle, articular disc, articular capsule and ligaments. The tumors that will be 
formed in this region will also develop from bone and soft tissue origin.
The most common TMJ-specific benign tumors are classified after a brief literature review. Our 
classification also includes the osteoma of the TMJ, other than World Health Organization’s 
(WHO) classification of soft tissue and bone tumors [2]. This benign tumor also included in 
the classification because of its higher frequency in the literature (Table 1).
Table 1 represents benign TMJ tumors. These tumors are classified under two section.
2. Cartilage tumors
Tumors producing a chondroid matrix will be described in this group. Many benign cartilage 
tumors are asymptomatic. Radiographic findings are critical to diagnosis of cartilaginous tumors.
2.1. Osteochondroma
Osteochondroma is a common slow-growing tumor that cartilage-capped bony projection 
arising from the outside surface of bone containing a marrow cavity that is continuous with 
that of the underlying bone appears close to the growth plate at the end of long bones [3]. 
In very few cases of temporomandibular joint, osteochondroma have been reported [4]. 
Osteochondroma is usually located at the medial surface of mandibular condyle [5]. The aver-
age age of occurrence is 16.5 and males are affected 3 times as often as females [6].
TMJ-specific benign tumors
Bone tumors 1. Cartilage tumors Osteochondroma
Chondroma
Chondroblastoma
Synovial chondromatosis
2. Osteogenic tumors Osteoma
Osteoid osteoma
Ostaoblastoma
3. Giant cell tumors Giant cell tumor
4. Vascular tumors Hemangioma
5. Lipogenic tumors Lipoma
6. Bone-related odontogenic tumors Ossifying fibroma
Soft tissue tumors 1. Fibrohistiocytic tumors Pigmented villonodular synovitis
2. Tumors of uncertain differentiation Juxta-articular myxoma
Table 1. Benign temporomandibular joint tumors.
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The most common clinical symptoms are malocclusion, with unilateral posterior open bite on 
the affected side and a crossbite on the contralateral side, and progressive facial asymmetry, 
limited and often painful mandibular movements and clicking [7, 8].
The reason for osteochondroma is uncertain, but traumatic, developmental, neoplastic and 
reparative occasions have been considered as possible factors [6, 9]. The most commonly 
accepted view is a metaplastic change of the periosteum and/or the osteochondral layer in the 
condyle, leading to the production of cartilage, which subsequently ossifies [8]. Complications 
of OC are osseous deformity, fracture, vascular compromise, bursa generation and malignant 
transformation [6]. CT can provide excellent anatomy of the lesion and demonstrate calcifica-
tion in the cartilage cap whereas MRI confirms the diagnosis by demonstrating the cartilagi-
nous cap [4].
The differential diagnosis of benign neoplasms known to involve the mandibular condyle 
includes osteoma, osteoblastoma, chondroma, chondroblastoma and osteochondroma. 
Osteomas are benign tumors that consist primarily of mature, compact, cancellous bone 
[9]. Chondromas consist of well-defined lobules of mature hyaline cartilage that may con-
tain areas of calcification. Chondroblastomas consist of a proliferation of immature car-
tilage cells, with focal production of a variably differentiated cartilaginous matrix [10]. 
Osteochondroma is presumed to arise from herniation of cartilage through the epiphyseal 
plate in the formative years. Radiographically, the lesion is easily differentiated from chon-
droma because it is most frequently an extraneous appendage, rather than a rarefaction 
within the normal jaw confines, and is more radiopaque, which represents its true ossifica-
tion [11].
Osteochondromas can be treated by total condylectomy or local resection of the lesion and 
condylar replacement if the tumor involves the mandibular condyle. On the other hand, if the 
tumor affects limited part of the condylar surface, preservation of the remaining part of the 
condyle and reshaping can be done [6, 12].
In the case of an osteochondroma of the author of this chapter, Dr Karasu, the tumor was 
removed under general anesthesia. On a panoramic radiograph, a well-defined, bone-like, 
radiopaque mass was seen in the left condylar head (Figure 1). Axial and coronal com-
puted tomographic (CT) scans revealed an opaque mass around the mandibular condyle 
(Figures 2 and 3). The patient’s three-dimensional CT image showed a large mass in the 
anteromedial region of the left condyle (Figure 4). The tumor was excised under gen-
eral anesthesia. The upper and lower compartments of the temporomandibular joint were 
accessed through an auriculotemporal approach. The surgical field was expanded with 
retraction along the masseter muscle downward. The disc, which adhered to the lesion 
at the anterior aspect of the condyle, was resected. The tumor was resected en bloc. The 
lesion could be easily separated from the surrounding tissues (Figure 5). Histologically, 
it was noted that the nodular mass was covered with a proliferative cap of cartilage with 
underlying zones of cancellous bone and irregular calcified cartilage. The osteocytes 
and chondrocytes were individually housed in a lacuna with a single nucleus (Figure 6). 
Sixteen-year follow-up assessments revealed satisfactory function and occlusion. There 
was no evidence of recurrence [11].
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2.2. Chondroma
Chondroma is a rare, benign tumor of mature hyaline cartilage of mesenchymal origin [13]. 
Chondromas, are common in the small bones of the hands and feet, but are extremely rare 
in the TMJ area [14, 15]. Chondromas are classified into three types as (a) enchondroma that 
arises from medullary cavity, (b) juxtacortical that originate adjacent to the periosteum below 
Figure 3. Coronal CT scan, showing localization of the osteochondroma.
Figure 1. Panoramic radiograph, showing a bone-like, radiopaque mass in the left condylar head.
Figure 2. Axial CT scan, showing a well-defined, opaque mass.
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the cortical face and (c) extra-skeletal that can be seen in the tongue and buccal mucosa [16, 17]. 
Chondromas are equally seen in men and women and most patients are 30–40 years old [14].
Chondromas are generally asymptomatic. Its signs and symptoms can mimic those of patients 
with more common disorders of facial asymmetry or dysfunction of the temporomandibular 
joint as clicking, limited mouth opening and deviation [18].
Figure 4. Three-dimensional CT view of the osteochondroma.
Figure 5. Mass resected from the left condyle.
Figure 6. Histopathological aspect of the osteochondroma. The cancellous bone is surfaced by a cap of hyaline cartilage 
(HC). A zone of endochondral ossification (EO) appears between the cartilaginous cap and underlying cancellous bone 
(hematoxylin and eosin; magnification, 200).
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Radiographically, chondromas are irregular radiolucent or mottled region of the bone. There 
may be some calcification foci ranging from powder like to dense aggregates [19].
The differential diagnosis for bony or cartilaginous hyperplastic lesion of the temporoman-
dibular joint may include condylar hyperplasia, osteochondroma, osteoma, chondroma, 
osteoblastoma, fibrous dysplasia, ossifying fibroma (OF), chondromyxoid fibromas, synovial 
chondromatosis, chondroblastoma, chondrosarcoma and osteosarcoma [20, 21].
Chondromas can be treated as low-grade chondrosarcomas by surgical treatment of man-
dibular condyle to avoid recurrence [13].
2.3. Chondroblastoma
Chondroblastoma is a rare benign, cartilaginous, destructive tumor derived from immature 
cartilage cells which occurs infrequently in the head and neck area [22, 23]. Most chondro-
blastoma cases arise in the epiphysis of long bones such as distal femur, proximal tibia and 
proximal humerus [24]. It is more common in women [25].
Chondroblastoma shows similar clinical symptoms associated with temporomandibular 
disorders such as sound in the joint, decreased range of motion, swelling, pain, trismus and 
changing occlusion. If chondroblastoma occurs at the temporal bone, additional symptoms 
such as otalgia, paresthesia, hearing loss, ear noise and facial nerve weakness may be seen [26].
Computerized imaging (CT) and magnetic resonance imaging (MRI) are the most common 
diagnostic imaging techniques to identify chondroblastoma. On imaging, round radiolucent 
lesions with sharp bony edges are found in bone [27].
Differential diagnosis should be done with chondrosarcoma, chondromyxoid fibroma, syno-
vial sarcoma, synovial chondromatosis and aneurysmal bone cyst. Biopsy is necessary for the 
definite diagnosis [28, 29].
Treatment alternatives are curettage, resection and excision. Chondroblastoma can be treated 
by conservative curettage when infiltration of bone has not occurred or is limited. Complete 
excision of the tumor reduces recurrence [30].
In the case of a chondroblastoma of the authors of this chapter, Dr Oncul and Dr Yurttutan, 
the tumor was removed under general anesthesia. A 35-year-old female patient had com-
plaint of pain and asymmetry. The patient’s three-dimensional CT image showed a large 
mass in the anteromedial region of the left condyle (Figure 7). The tumor was resected via a 
pre-auricular access (Figures 8 and 9), the mass was removed by performing condylectomy 
(Figure 10).
2.4. Synovial chondromatosis
Synovial chondromatosis (SC) is a rare benign nodular cartilaginous proliferative non-neo-
plastic lesion arising from the synovial membrane or the fibro-cartilaginous disc of the joints 
becoming loose bodies within the joint space [3, 31]. The first report of SC of the temporoman-
dibular joint (TMJ) was in 1776 [32].
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The etiology of SC is unclear but it is thought to be a trauma history, occlusal disorders, brux-
ism and degenerative arthritis [33]. SC of TMJ is 2.5 times more common in females, mainly 
between 30 and 50 years old [34].
SC has three histological stages:
1. metaplasia found in the synovial membrane without the presence of detached particles.
2. metaplasia found in the synovial membrane with the presence of detached particles.
3. presence of detached particles which may vary in size [3].
Clinical signs and symptoms of SC is local diffuse pain, pre-auricular swelling, limitation of 
mandibular movement, joint sounds, tenderness, deviation of mouth opening [35].
Computerized imaging (CT), magnetic resonance imaging (MRI) and orthopantomography 
are the most common diagnostic imaging techniques. The main findings are widening of the 
joint space, changes in bone surface of joint and calcified loose bodies [36].
Figure 7. Three-dimensional CT view of the chondroblastoma.
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Figure 9. Intraoperative view after the excision of chondroblastoma.
Figure 8. Intraoperative view of the condyle with the chondroblastoma.
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Differential diagnosis should be done with internal derangements, osteoarthritis, osteochon-
dromas, villonodular synovitis, chondroblastoma and focal osteochondritis [37].
Synovectomy with removal of loose body from the joint space is the most preferred pro-
cedure. It can be applied in combination with discectomy or condylectomy. No recurrence 
when loose bodies are removed [38].
3. Osteogenic tumors
Osteogenic tumors are defined as neoplasms that produce an osteoid or bony matrix.
3.1. Osteoma
Osteomas are benign osteogenic tumors involving compact or cancellous bone proliferation and 
arising from periosteum (peripheral osteoma), endosteum (central osteoma) and even extra-
skeletal soft tissue, but they are actually hamartomas that can be seen in membranous bone [39, 
40]. Most osteomas of the maxillofacial region occur in the mandible. Peripheral osteomas typi-
cally arise at the inferior border of the mandibular body [41, 42]. Only a few cases involving the 
temporomandibular joint have been reported [43]. Men seem to be more affected than women. 
The exact cause is unknown, whereas belief in reactive and neoplastic theories maintains [1].
Histologically, compact type osteomas (ivory) consist primarily of dense lamellar bone, and 
cancellous type osteomas have an abundance of bone marrow [42].
The growth of osteomas occurring in TMJ may result in morphologic and functional distur-
bances, including facial asymmetry, malocclusion and limited mouth opening [44].
Figure 10. Macroscopic view of the pathology.
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Figure 11. Preoperative frontal view of the mandibular asymmetry.
Radiographically, osteoma appears as a well-defined uniform radiopacity or as well-defined 
radiopacity with evidence of internal trabecular structure. In their centers such masses may 
exhibit a mixed radiolucent-radiopaque appearance depending on the amount of marrow 
tissues present [39, 45]. Panoramic radiography, CT, MRI and radionuclide scanning (scintig-
raphy) have been utilized for imaging of osteomas of the TMJ region [46].
The differential diagnosis is established with exostoses, osteoid osteoma and osteoblastoma 
[46]. Osteomas of the condyle are lobulated; conversely, hyperplasia results in enlargement 
of the condyle that retains in its inventive form [47]. Osteoid osteoma and osteoblastoma are 
frequently painful and grow more rapidly than peripheral osteoma [1].
Large osteomas at TMJ can be treated by condylectomy and tumor resection. No recurrence 
is reported after surgery [43].
In the case of an osteoma of the author of this chapter, Dr Oncul, the tumor was removed under 
general anesthesia. A 45-year-old male patient had complaint of habitual luxation which had 
been present for 5 years and asymmetry (Figure 11). The tumor was resected via a pre-auric-
ular access (Figure 12), the mass was removed by performing a condylectomy, preserving the 
articular meniscus (Figure 13). Microscopic examination showed a central nidus surrounded 
by a layer of dense cortical bone. The nidus consisted inconsiderable amount of interstitial con-
nective tissue. No abnormal mitosis or malignancy findings were seen (Figure 14) [48].
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3.2. Osteoid osteoma
Osteoid osteoma is a benign bone-forming tumor characterized by small size, limited growth 
potential and disproportionate pain. Osteoid osteoma usually affects children and adoles-
cents, although it is occasionally seen in older individuals. It is more common in males [2]. 
Osteoid osteoma is rarely described in TMJ [49].
Figure 12. Intraoperative view of the condyle with the osteoma.
Figure 13. Macroscopic view of the pathology.
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The trio of complaints for osteoid osteoma of the jaw is pain, swelling and tenderness [50].
The most typical symptom of osteoid osteoma is spontaneous pain, usually responsive to 
non-steroidal anti-inflammatory drugs (NSAIDs). At first, the pain is light and discontinuous, 
but later becomes severe and constant [51].
A characteristic radiographic finding is ‘nidus’, which represents a small, round, clear, non-
calcified, well-demarcated radiolucency in the subjacent cortex surrounded by sclerotic bone, 
not larger than 2 cm [3]. CT and cone beam computed tomography (CBCT) are superior to 
MRI in diagnosing and precisely localizing these bone tumors in TMJ [46, 50].
The differential diagnosis of osteoid osteoma is established which includes bone island/soli-
tary enostosis, intracortical bone abscess (Brodie abscess), sclerosing forms of osteomyelitis 
and early diagnosis of osteosarcoma or osteoblastoma, fibroma or fibrous dysplasia [14, 51].
However, the sequestrum of osteomyelitis is irregular rather than a well-demarcated round 
lesion and is usually located in the bone marrow, not in the cortical plate [50].
The most important criterion to distinguish osteoid osteoma from osteoblastoma: osteoid 
osteomas are typically <1 cm in size, whereas osteoblast [52] stomas are generally >2 cm. An 
osteoid osteoma usually contains only a single calcification, whereas an osteoblastoma con-
tains multiple calcifications. However, the osteoblastoma differs from the osteoid osteoma in 
that it has a greater growth potential, is frequently painless, and becomes heavily calcified 
when subjected to radiological examination [51].
Surgical removal of the osteoid osteoma is the most advised treatment option if the pain 
is not relieved by NSAIDs. En bloc excision or cortical shaving and curettage of the nidus 
are sufficient and can provide immediate relief of symptoms. After the nidus is removed, all 
symptoms eventually disappear [46, 50, 53].
3.3. Osteoblastoma
Osteoblastoma is a rare benign bone-forming neoplasm which produces woven bone spic-
ules, which are bordered by prominent osteoblasts. Osteoblastoma is uncommon, accounting 
for about 1% of all bone tumors and is more common in women and affects patients in the age 
Figure 14. Histopathological aspect of the osteoma.
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range of 10–30 years [2]. The tumor normally involves the long bones, spine and sacrum. Less 
than 10% of osteoblastomas are located in the maxillofacial region [54, 55]. Osteoblastoma 
involving the TMJ is very rare [56].
Complaints for osteoblastoma are dull persistent pain and swelling [57]. Even if NSAIDs is 
used, the pain will not decrease in contrast to osteoid osteoma [56].
Osteoblastoma has identical histological features to osteoid osteoma [2]. Osteoblastomas are 
characterized by numerous plump osteoblastic cells producing and lining the haphazardly 
arranged lesional trabeculae of osteoid and woven bone. Numerous blood vessels are often 
seen in the osteoblastic and fibrous stroma filling the lesional inter-trabecular areas. Five scat-
tered multinucleated giant cells resembling osteoclasts are also generally seen. Mitotic figures 
may be seen, but these are usually sparse and have a normal configuration [58]. Osteoblastoma 
and osteoid osteoma are histopathologically very similar, and diagnosis is often based on the 
size of the lesion, with an osteoid osteoma being less than 1 cm in diameter and an osteoblas-
toma being larger than 2 cm [59].
The radiographic features are well-defined expansile lesions contain small scattered calcifica-
tions [59]. Radiographic differential diagnosis of osteoblastoma should include osteogenic 
sarcoma, chondrosarcoma, osteoid osteoma and aneurysmal bone cyst [3].
The treatment choice of osteoblastoma for TMJ is conservative surgery. Recurrences after 
complete excision are uncommon [55].
4. Giant cell tumors
Almost every lesion in the bone can contain giant cells, sometimes a large number. To be 
characterized as a giant cell tumor (GCT), the neoplasm must have oval mononuclear cells 
and more or less evenly distributed giant cells.
4.1. Giant cell tumor
Giant cell tumors (GCTs) are a benign, locally aggressive neoplasm which is composed of 
sheets of neoplastic ovoid mononuclear cells interspersed with uniformly distributed large, 
osteoclast-like giant cells. GCT is classified as an “intermediate locally aggressive, rarely 
metastasizing” bone tumor by World Health Organization (WHO) [2]. The prevalence of 
GCTs peaks in adults in their 30s or 40s [60, 61]. GCTs are frequently identified at the 
epiphyses of long bones, particularly in the proximal tibia, distal femur and distal radius 
[62]. Craniofacial bone involvement is rare but has been reported to occur in the mandible, 
temporal bone, maxilla, occipital and sphenoid [63]. Less than 30 cases of GCT in the TMJ 
have been reported. Patients with GCTs at TMJ are presented with progressive pain and 
swelling. Due to compression or local invasion, hearing impairment, facial nerve paraly-
sis, headache, visual area defects, double vision, visual loss, tinnitus, otalgia, vertigo and 
trismus can occur [64]. Discomforts as jaw locking, mandibular deviation and clicking can 
also be seen. These three symptoms and signs are also common with temporomandibular 
disorders [65].
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Recent experiments have characterized GCTs as consisting of three cell types: (1) osteoclast-
like, multinucleated giant cells; (2) round mononuclear cells resembling monocytes and (3) 
spindle-shaped, fibroblast-like stromal cells [66].
GCTs appear lytic, subarticular, eccentrically located and usually lack a sclerotic rim on radio-
graphs. Local bony destruction, cortical breakthrough and soft tissue expansion may also be 
seen [67]. MRI is the preferred imaging modality for GCTs, as the diagnostic accuracy of MRI 
is high and it can detect soft tissue and intra-articular extension [68].
Important differential diagnoses of GCTs are giant cell reparative granuloma, hyperpara-
thyroidism, non-ossifying fibroma, chondroblastoma, solid areas of aneurysmal bone cyst, 
malignant fibrous histiocytoma and osteogenic sarcoma [69].
Various modalities have been used in the treatment of GCTs including surgery, cryotherapy, 
radiotherapy, calcitonin, corticosteroids, a interferon and recently, the monoclonal antibody 
against receptor activator of nuclear factor kappa-B ligand (RANKL) denosumab [70, 71]. 
Intralesional curettage is not recommended for GCTs in the skull base because recurrence in 
this location would complicate further treatment and make it unresectable for reoperation [72]. 
However, because of the complexity of the craniofacial anatomy, wide excisions or en bloc resec-
tions for head and neck GCTs should be attempted. Radiotherapy can be applied for cases where 
wide excision cannot be achieved or for patients who are not fit for surgery [73]. But radio-
therapy as a sole treatment modality is not recommended due to high (60–70%) recurrence rates 
[74]. Denosumab, a receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitor can 
be used in recurrent and unresectable GCTs [75]. Denosumab specifically inhibits osteoclast-
mediated bone destruction by GCTs [76]. Denosumab can be used to reduce the tumor size pre-
operatively [74].
5. Vascular tumors
Primary vascular tumors are rare in bone. Hemangiomas occur as coincidental findings in 
the skull or spine. X-ray features are almost always diagnostic. They rarely cause clinical 
symptoms.
5.1. Hemangioma
lntraosseous hemangiomas are benign vasoformative neoplasm or developmental condition of 
endothelial origin tumors occurring most often in the maxilla and mandible after the skull and 
vertebrae [2]. Clinically, hemangiomas of the mandible are often presented as slow-growing 
expansile lesions. They occur twice as often in women. Hemangiomas present as radiolucent 
lesions, which may have a unicystic- or multicystic-like “soap bubbly,” “honeycomb” or “tra-
beculated” appearance [77]. The differential diagnosis for this radiographic appearance must 
also include: ameloblastoma, odontogenic keratocyst, central giant cell granulomata, giant cell 
tumor of hyperparathyroidism, aneurysmal bone cyst and metastatic lesions [78]. Treatment 
may include embolization, sclerosing agents and surgery [79].
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6. Lipogenic tumors
Lipomas are rare in the bones and are found incidentally in the X-rays and contain calcaneus. 
Radiography shows a well-defined area of lucency with a central calcification area.
6.1. Intraosseous lipoma
Lipoma of bone is a benign neoplasm of adipocytes that arises within the medullary cavity, 
cortex or on the surface of bone. Lipoma of bone is rare and accounts for less than 0.1% of 
primary bone tumors [2]. The jaw is its most uncommon bone location.
Etiology of lipoma is not clear but possible etiological factors may be dental trauma, disrup-
tion of the post-extraction healing process, retention of radicular remains, medullary bone 
infarction (common in elderly) or osteoporotic bones [80–82]. They are generally asymptom-
atic, being diagnosed by chance during a radiographic examination. Symptoms depend on 
its size, location, time of evolution and growth rate. Pain, swelling and numbness may occur 
[83, 84]. Radiological appearance of intraosseous lipoma is well-circumscribed radiolucent 
unilocular or multilocular lesion. Treatment involves curettage of the lesion, with or without 
grafting the cavity [85].
7. Bone-related odontogenic tumors
Odontogenic tumors are rare, some of them very rare, but they can be an important diagnostic 
and therapeutic problem.
7.1. Ossifying fibroma
Ossifying fibroma (OF) is a well-demarcated lesion composed of fibrocellular tissue and min-
eralized material of varying appearances [86]. The mandible (especially the molar region) is 
affected more often than the maxilla [87]. Ossifying fibroma is mainly diagnosed between 
the second and fourth decades of life, with women being affected more frequently than men 
[88, 89]. Ossifying fibroma of craniofacial bones is composed of two components: fibrous 
stroma and bone elements that show various degrees of maturation [90]. The treatment of 
choice is surgical excision. Enucleation and curettage could be suitable for small and well-
defined lesions; however, larger masses require radical surgery [91]. Condylectomy may be 
performed with an immediate TMJ reconstruction [92].
8. Fibrohistiocytic tumors
Diffuse and localized forms of the giant cell tumor of the tendon sheath are more common 
with the descriptive category of fibrohistiocytic lesions.
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8.1. Pigmented villonodular synovitis
Pigmented villonodular synovitis (PVNS) is a rare, benign tumor but is a locally aggressive 
tumor of the synovial membrane with an annual incidence [93]. Lesions originate from the 
joint capsule, tendon sheath or bursae and occur most commonly in the knee, hip and ankle 
[94]. The etiology of PVNS is not clear and may result from chronic inflammation, trauma or 
represent a distinct neoplastic process [95–97]. It is considered as fibrohistiocytic tumor by the 
World Health Organization classification of bone and soft tissue tumors. Tenosynovial giant 
cell tumor, diffuse-type giant cell tumor, villonodular synovitis, giant cell tumor of the tendon 
sheath and nodular tenosynovitis are the synonyms of that tumor [2]. PVNS of the temporo-
mandibular joint (TMJ) is a rare variant with less than 80 cases reported in the literature [98]. 
This slow-growing tumor may be seen in all age groups. The peak age of occurrence is between 
30 and 50 ages [99]. PVNS has been shown to have a synovial cell origin immunophenotypi-
cally and is reported to involve myofibroblastic differentiation [100, 101]. The tumor is com-
posed of monocyte, multinucleated giant cells and foam cells distributing in a fibrous stroma, 
presenting hemosiderin deposition [102]. It has a higher gender predilection in females [103].
PVNS can enlarge into the middle cranial fossa, displacing the temporal lobe and invading the 
dura mater. Patients are generally present with an enlarging pre-auricular mass, pain, trismus 
or hearing loss [104]. The radiological appearance of PVNS on CT is a contrast-enhancing intra-
articular lesion originating in the glenoid fossa, with focal areas of hyperdensity or cysts. It 
produces variable bony remodeling or erosion of the adjacent bone [105]. On MRI, the most 
characteristic finding is a mass with low signal intensity on T1 and GRE-T2 weighted sequences, 
reflecting the deposition of blood degradation products. Occasionally, hyperintense areas on 
T1 or GRE-T2 sequences may appear due to the presence of lipids or cysts, respectively [106].
The differential diagnosis is established with osteoarthritic change, chondroblastoma, chon-
drosarcoma, aneurysmal bone cyst, rhabdomyosarcoma, plasmacytoma, cholesteatoma, 
intraosseous meningioma, reparative granuloma, tumoral calcium pyrophosphate dihydrate 
crystal deposition disease, chondroma of the tendon sheath, synovial chondromatosis, tendon 
sheath fibroma, synovial hemangioma, synovial sarcoma, embryonal rhabdomyosarcoma, 
giant cell granuloma, brown tumor and malignant fibrous histiocytoma [107, 108].
Therapy for PVNS of the TMJ and temporal bone remains surgical. PVNS of the temporal 
bone most commonly acquires the diffuse form of disease involving the contiguous synovial 
space with extension into adjacent structures. Accordingly, limited resection or curettage car-
ries a high rate of recurrence, whereas wide local resection, when feasible, is usually curative 
[104, 109]. The surgical approach must be carefully planned to allow for a complete removal 
of the tumor while minimizing surgical trauma [110].
9. Tumors of uncertain differentiation
For tumors in this category, in most cases, there is no clear idea on the differentiation line (or 
normal cellular counterpart) that these lesions repeat.
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9.1. Juxta-articular myxoma
Juxta-articular myxoma is a rare, benign soft tissue tumor that usually arises in the vicinity of 
a large joint, has histological features resembling a cellular myxoma [2]. There are reported 
cases involving myxomas of the knee, shoulder, elbow, wrist and hip. To our knowledge, 
however, there is just one reported cases of juxta-articular myxomas of the temporomandibu-
lar joint (TMJ) [111]. The juxta-articular myxoma resembles the common myxoma, however, 
it is distinguished by its association with the underlying connective tissue components of 
the joint. These include the associated tendons, joint capsule, meniscus and synovium [112]. 
Palpable swelling is occasionally associated with pain, tenderness or a functional limitation 
may occur [113, 114]. Like the common myxoma, the treatment of choice for the juxta-articular 
myxomas is complete local excision [115]. Tumors extending into the infratemporal fossa are 
notoriously difficult to resect [116].
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